125I-4-(2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-8}{1,3,5}triazin 5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor

Molecular Pharmacology

Volumn 48, Issue 6, 1995, Pages 970-974

  Palmer, Timothy M ^a   Pougher, Simon M ^b   Jacobson, Kenneth A ^c   Stiles, Gary L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ASTRAZENECA   (United Kingdom)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; BW A1433U; IODINE 125; PHENYLISOPROPYLADENOSINE; RADIOLIGAND; XANTHINE DERIVATIVE; ADENOSINE RECEPTOR; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CATTLE; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; HAMSTER; METABOLISM; METHODOLOGY; PHYSIOLOGY; RADIOASSAY; SYNTHESIS;

ANIMALS; CATTLE; CHO CELLS; CRICETINAE; IODINE RADIOISOTOPES; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; RECOMBINANT PROTEINS; TRIAZINES; TRIAZOLES;

EID: 0029414908     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Olah, M. E., and G. L. Stiles. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:581-606 (1995).
2. Tucker, A. L., and J. Linden. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27:62-67 (1993).
3. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251:888-893 (1989).
4. 2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc. Natl. Acad. Sci. USA 86:6572-6576 (1989).
5. 125I]iodophenyl)ethylamino]adenosine. Mol. Pharmacol. 47:307-313 (1995).
6. Sarges, R., H. R. Howard, R. G. Browne, L. A. Lebel, P. A. Seymour, and B. K. Koe. 4-Amino[11,2,4]triazolo[4,3-α]-quinoxalines: a novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J. Med. Chem. 33:2240-2254 (1990).
7. 2-adenosine receptor antagonist in vitro and in vivo. FEBS Lett. 323:141-144 (1993).
8. 2 receptor antagonist. Eur. J. Pharmacol. 267:335-341 (1994).
9. 2 adenosine receptor antagonist, to rat brain membranes. Mol. Pharmacol. 46:817-822 (1995).
10. 2-adenosine receptors on cardiomyocytes. J. Pharmacol. Exp. Ther. 254: 1017-1023 (1990).
11. 2a selective adenosine receptor antagonist. Br. J. Pharmacol. 115:1096-1102 (1995).
12. 3 adenosine receptor. Mol. Pharmacol. 45:978-982 (1994).
13. 3 adenosine receptor. J. Biol. Chem. 270:16895-16902 (1995).
14. 2b-adenosine receptor. Mol. Endocrinol. 6:1598-1604 (1992).
15. 2 dopamine receptors in rat striaturn. Mol. Brain Res. 14:186-195 (1992).
16. 2-adenosine receptor subtype. Mol. Endocrinol. 6:384-393 (1992).
17. Cook, S. J., B. Rubinfeld, I. Albert, and F. McCormick. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:3475-3485 (1993).
18. DeLean, A., A. A. Hancock, and R. J. Lefkowitz. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 22:3099-3108 (1982).
19. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
20. 2 adenosine receptor. J. Recept. Res. 13:961-973 (1993).
21. 2 binding sites in striatal membranes from mammalian brain. Drug Dev. Res. 15:31-46 (1988).
22. 2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol. 39:130-135 (1991).
23. 2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction. Mol. Pharmacol. 39:524-530 (1991).